2019
DOI: 10.1016/j.jsbmb.2019.03.015
|View full text |Cite
|
Sign up to set email alerts
|

An evaluation of total 25-hydroxyvitamin D assay standardization: Where are we today?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
18
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(18 citation statements)
references
References 23 publications
0
18
0
Order By: Relevance
“…The analytical difficulties related to the measurement of vitamin D metabolites may lead to misclassification of ‘low' vitamin D status. The variations in analytical techniques and assays may cause the large variability in laboratory measurements of vitamin D status and the systematic “errors” [ 36 – 45 ]. In our study, the serum 25(OH)D level of ≥30 ng/ml was considered as the normal level and 20 to 29 ng/ml as vitamin D insufficiency, whereas serum 25(OH)D levels of <20 ng/ml were considered as an indicative of vitamin D deficiency.…”
Section: Discussionmentioning
confidence: 99%
“…The analytical difficulties related to the measurement of vitamin D metabolites may lead to misclassification of ‘low' vitamin D status. The variations in analytical techniques and assays may cause the large variability in laboratory measurements of vitamin D status and the systematic “errors” [ 36 – 45 ]. In our study, the serum 25(OH)D level of ≥30 ng/ml was considered as the normal level and 20 to 29 ng/ml as vitamin D insufficiency, whereas serum 25(OH)D levels of <20 ng/ml were considered as an indicative of vitamin D deficiency.…”
Section: Discussionmentioning
confidence: 99%
“…Due to this analytical variability and pre‐analytical factors for serum 25‐OHD variation (season, sun exposure, and skin type), no evidence‐based international consensus on a human vitamin D RI exists 26 . It is, however, recognized that 25‐OHD concentrations below 30 nmol/L increase the risk of poor musculoskeletal health, while concentrations between 50‐125 nmol/L appear to be safe and sufficient 27‐29 . Cases of vitamin D toxicity are rare and associated with serum 25‐OHD concentrations above 300 nmol/L 28…”
Section: Discussionmentioning
confidence: 99%
“…26 It is, however, recognized that 25-OHD concentrations below 30 nmol/L increase the risk of poor musculoskeletal health, while concentrations between 50-125 nmol/L appear to be safe and sufficient. [27][28][29] The CV of 6% calculated between the DBS1 and DBS2 pairs encompass both the within-batch analytical CV of the assay for chimpanzees (intra-assay variation) and the variations due to the DBS quality (spot size, diffusion of blood). The result is comparable to the reported intra-assay CV for the human DBS assay of <10%, thus suggesting little variation due to DBS quality in this study.…”
Section: Discussionmentioning
confidence: 99%
“…An essential point that needs repeating is that laboratories cannot assume that just because an immunoassay assay is CDC-certified it will function appropriately in their hands (89,90) . We recommend a testing period in order to verify that an immunoassay is standardised especially since there is generally very little an individual laboratory can do to 'calibrate' an immunoassay.…”
Section: Vdsp: a Ready Solutionmentioning
confidence: 99%